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Thrombocytopenia is a consistent finding and one of the earliest hematological abnormalities in horses acutely infected
with equine infectious anemia virus (EIAV), a lentivirus closely related to human immunodeficiency virus. Multifactorial
mechanisms, including immune-mediated platelet destruction and impaired platelet production, are implicated in the
pathogenesis of EIAV-associated thrombocytopenia. This study was undertaken to investigate whether regenerative throm-
bopoiesis and platelet destruction occurred in ponies acutely infected with EIAV. Circulating large, immature platelets were
increased in ponies acutely infected with EIAV late in the infection when platelet count was at a nadir. Morphometric analysis
of bone marrow from acutely infected ponies revealed significant increased in megakaryocyte area and megakaryocyte
nuclear area. A trend toward increased numbers of megakaryocytes was also observed. Platelets from acutely infected
ponies had increased surface-bound fibrinogen and ultrastructural changes consistent with in vivo platelet activation.
Platelets also had hypofunctional aggregation responses to three agonists in vitro. We conclude that thrombocytopenia in
ponies acutely infected with EIAV is regenerative and suggest that bone marrow platelet production is not severely
compromised in these ponies. Our findings reveal that in vivo platelet activation occurs in ponies acutely infected with EIAV,
and as a result platelets are hypofunctional in vitro. Activation of platelets in vivo may cause platelet degranulation or
formation of platelet aggregates, which would result in removal of these damages platelets from circulation. This may
represent a form of nonimmune-mediated platelet destruction in ponies acutely infected with EIAV. © 1999 Academic Press
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Thrombocytopenia is a common hematological abnor-
ality in people infected with human immunodeficiency
irus (HIV) (Peltier et al., 1991). Accelerated immune-
ediated platelet destruction and defective or de-
reased thrombopoiesis are implicated in the pathogen-
sis of HIV-associated thrombocytopenia (Morris et al.,
982; Abrams et al., 1986; Karpatkin, 1988; Ballem et al.,
992). Equine infectious anemia virus (EIAV), a lentivirus
hat causes lifelong infection in Equidae, is closely re-
ated to human immunodeficiency virus, type 1 (Montag-
ier et al., 1984; Stephens et al., 1986). As with HIV,
hrombocytopenia is a common hematological abnor-
This work was supported by funds from the State of North Carolina
nd by Public Health Service Grant K11-AI 00963 from the National
nstitutes of Health (D.C.S.).
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ayetteville Road, Chapel Hill, North Carolina 27516. Fax: (919) 966-
146. E-mail: krussell@med.unc.edu.
2 Present address: Department of Veterinary Clinical Sciences, Col-
ege of Veterinary Medicine, Washington State University, Pullman,nashington 99164.
7ality of EIAV infection (Clabough et al., 1991) and mul-
iple mechanisms are likely involved in the pathogenesis
Clabough et al., 1991; Crawford et al., 1996; Wardrop et
l., 1996; Tornquist and Crawford, 1997; Tornquist et al.,
997).
In ponies acutely infected with EIAV, the onset of
hrombocytopenia is closely associated with fever and
iremia and platelet numbers rapidly rebound as fever
nd viremia subside (Clabough et al., 1991). Platelets
rom thrombocytopenic horses acutely infected with vir-
lent EIAV have decreased life spans (Crawford et al.,
996) and increased surface immunoglobulin, consistent
ith peripheral immune-mediated platelet destruction
Clabough et al., 1991). However, Arabian foals with se-
ere combined immunodeficiency (SCID) that are in-
ected with EIAV become thrombocytopenic just as rap-
dly and severely as immune-competent Arabian foals
hat are infected with the virus (Wardrop et al., 1996). This
inding establishes that specific immune responses are
ot necessary for the production of thrombocytopenia in
IAV-infected horses. Although diminished platelet pro-
uction is most likely a significant component of EIAV-
ssociated thrombocytopenia (Crawford et al., 1996;
ornquist and Crawford, 1997; Tornquist et al., 1997),
onimmune-mediated platelet destruction may be an al-
0042-6822/99 $30.00
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8 RUSSELL ET AL.ernative explanation for the thrombocytopenia observed
n EIAV-infected SCID foals. This hypothesis is supported
y the observation that platelet life spans are decreased
n both immunocompetent and SCID foals infected with
IAV (Crawford et al., 1996).
During acute viral infections, platelets can become acti-
ated in vivo, with resultant degranulation, aggregation, and
emoval from circulation (Terada et al., 1966; Chernesky et
l., 1973; Turpie et al., 1973; Sottnek et al., 1975; Scott et al.,
978; Pineau et al., 1980; Kazatchkine et al., 1984; Boud-
eaux et al., 1990a,b). Platelet activation can arise due to
ntibody or complement binding to platelet surface mem-
ranes (Clancy et al., 1972; Karpatkin and Lackner, 1975;
eyns et al., 1978; Stuart et al., 1981; Yanabu et al., 1991;
hristie and Swinehart, 1992), direct interaction between
latelets and virus (Jerushalmy et al., 1961; Terada et al.,
966; Turpie et al., 1973; Sottnek et al., 1975; Scott et al.,
978; Pineau et al., 1980; Boudreaux et al., 1990a,b), inter-
ction between inflammatory cells (Weksler, 1988; Hensen,
990; Faint, 1992), or through effects of circulating cytokines
Oleksowicz et al., 1991, 1994; Burstein, 1994; Peng et al.,
994). Direct or indirect damage to vascular endothelium
ay cause release of platelet agonists from endothelial
ells, resulting in platelet activation and aggregation with
ubsequent removal of platelets from circulation (Curwen
t al., 1980; Cossgriff, 1989). If EIAV-associated thrombocy-
openia is the result of peripheral destructive processes,
hen platelet regenerative responses should be evident in
eripheral blood and bone marrow. If platelet destruction
ccurs secondary to platelet activation and damage in vivo,
irculating platelets should be activated and hypofunc-
ional.
In the present study, we show that thrombocytopenic
onies acutely infected with EIAV had increased percent-
ges of young platelets in circulation and evidence of
ncreased thrombopoiesis in the bone marrow. These
indings suggest that bone marrow platelet production in
onies acutely infected with EIAV is not severely com-
romised. Platelets from these ponies had increased
ibrinogen bound to platelet surface membranes and
ltrastructural changes consistent with in vivo activation.
hese platelets exhibited hypofunctional in vitro aggre-
ation responses with three different platelet agonists.
he additional finding that circulating platelets are acti-
ated and hypofunctional during acute infection sug-
ests that enhanced peripheral platelet destruction may
e an additional mechanism in the pathogenesis of EIAV-
ssociated thrombocytopenia.
RESULTS
latelet size and the percentage of reticulated
latelets are increased in thrombocytopenic ponies
cutely infected with virulent EIAV
During thrombocytopenia secondary to peripheral
latelet destruction, bone marrow platelet production ahould accelerate, increasing the percentage of young
latelets in circulation (Ebbe et al., 1968; Harker, 1970;
morosi et al., 1971; Odell et al., 1976; Karpatkin, 1978;
evin and Bessman, 1983; Corash et al., 1987). Young
latelets are typically larger than mature, older platelets
McDonald et al., 1964; Minter and Ingram, 1967; Garg et
l., 1971). We examined peripheral blood from ponies
cutely infected with EIAV to determine mean platelet
olume (MPV) when ponies were thrombocytopenic. Pe-
ipheral platelet counts and MPV from six ponies acutely
nfected with EIAV were compared before infection and
ate in infection when ponies were febrile, thrombocyto-
enic (,75,000 platelets/ml), and viremic (Fig. 1). A sig-
ificant decrease in platelet counts (P 5 0.004) in EIAV-
nfected ponies occurred late in infection, with a corre-
ponding significant increase in MPV (P 5 0.005)
ompared to preinfection values. At this time, MPV
mean 6 SD, 6.80 6 0.916 fl) was above the normal
eference range (4.3–6.1 fl) for the clinical pathology
aboratory at North Carolina State University, College of
eterinary Medicine.
Reticulated platelets are young platelets that have
een recently released from bone marrow and contain
n increased amount of mRNA (Ault and Nowles, 1995;
ale et al., 1995). We compared the percentage of circu-
ating reticulated platelets in six EIAV-infected ponies at
reinfection and late infection. A significant increase
P 5 0.01) in the percentage of reticulated platelets in
irculation was observed when ponies were thrombocy-
openic and had increased MPV. Preinfection, the ponies
ad a mean of 2.09% 6 0.37 SD circulating reticulated
latelets, whereas in the late infection period, infected
onies had a mean of 16.18% 6 6.65 SD. Two of the
onies recovered from the initial thrombocytopenic epi-
ode and were followed until platelet counts returned to
ormal (Fig. 2). In one of these ponies, as peripheral
latelet counts rebounded, the percentage of reticulated
latelets in circulation decreased. Reticulated platelets
rom this pony, maintained for .300 days postinfection,
ere determined on PID 339 and found to be 1.75%
ccompanied by a platelet count of 239,000 platelets/ml.
n the second pony, platelet counts showed a less vig-
rous recovery after the initial thrombocytopenic epi-
ode. A second increase in the percentage of reticulated
latelets during a severely thrombocytopenic episode
as observed around PID 35, when platelet numbers fell
o 26,000 platelets/ml.
one marrow thrombopoiesis is increased during
cute EIAV infection
We examined bone marrow megakaryocytes to deter-
ine if morphologic evidence of accelerated thrombo-
oiesis was present. The results of the morphometric
nalysis are summarized in Table 1. Total megakaryocyte
rea and nuclear area were significantly increased in
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9THROMBOCYTOPENIA AND EIAVone marrow from acutely infected ponies (n 5 4) com-
ared to uninfected controls (n 5 8). An increase in the
umber of megakaryocytes/mm2 was also observed in
he acutely infected ponies, but this finding was not
tatistically significant. No differences were seen in the
umber of bare megakaryocyte nuclei in either group.
latelets from acutely infected ponies are activated
n vivo
Because peripheral blood and bone marrow results
ere consistent with responsive thrombopoiesis, we hy-
othesized that in vivo platelet activation contributes to
nhanced peripheral destruction of platelets during
cute EIAV infection. The activation marker fibrinogen
Coller, 1985) and platelet ultrastructural morphology
Hovig, 1968; Sedar et al., 1974) were used to determine
hether platelets from acutely infected EIAV thrombocy-
openic ponies were activated in vivo.
Platelets for activation experiments were collected
rom 8 normal ponies and 5 EIAV-infected ponies at the
ate time period during the infection. Figure 3 shows
hat fibrinogen binding by platelets from EIAV ponies
t this time was significantly increased (P 5 0.0007)
ompared to normal control animals. Increased fibrin-
gen binding occurred when the ponies were throm-
ocytopenic, febrile, and viremic. Normal equine plate-
ets incubated with plasma from infected horses or
erum-free virus showed no evidence of increased
ibrinogen binding compared to autologous plasma,
ninfected plasma, or tissue culture media (data not
hown).
Ultrastructural morphology of platelets from four nor-
al uninfected ponies and three EIAV-infected ponies
ate in the infection period were examined by transmis-
ion electron microscopy (Figs. 4A–4H). Platelets from
IAV-infected ponies exhibited moderate to marked ab-
ormal ultrastructure (Figs. 4C–4H). In two of the ponies,
FIG. 1. Comparison of the relationship between platelet count and
nfected ponies. The mean 6 standard deviation is given (**P 5 0.003latelet shape change, marked pseudopodia formation, rnd centralization of granules were present (Figs. 4C–
F). In the third pony, a large amount of amorphous
ebris and very few intact, recognizable platelets were
resent (Figs. 4G and 4H).
latelets from thrombocytopenic ponies acutely
nfected with EIAV are hypofunctional in vitro
Ultrastructural studies revealed marked abnormalities
n platelet morphology, suggesting that these platelets
ay also be hypofunctional. In vitro platelet responses to
DP, collagen, and PAF were monitored preinfection and
arly, midway, and late during the 2-week acute infection
eriod. Preinfection values were compared with those at
ate infection, when ponies were thrombocytopenic and
isplayed clinical signs of fever, depression, and an-
rexia. At this point in time, statistically significant de-
reases in platelet responses to all three agonists were
een (Fig. 5).
DISCUSSION
Thrombocytopenia is an early and consistent hemato-
ogical abnormality in horses acutely infected with EIAV
nd multiple mechanisms appear to be important in the
athogenesis (Clabough et al., 1991; Crawford et al.,
996; Wardrop et al., 1996; Tornquist and Crawford, 1997;
ornquist et al., 1997). In this study, we showed that
hrombocytopenic, EIAV-infected ponies had a regener-
tive response to thrombocytopenia in the peripheral
lood and bone marrow. Additionally, in vivo platelet
ctivation occurred in these ponies and these platelets
ere hyporesponsive to common platelet agonists in
itro.
Increases in MPV are characteristic of disease pro-
esses associated with stimulation of thrombopoiesis,
uch as increased peripheral platelet destruction (Amo-
latelet volume (MPV) preinfection and late in infection in six acutely
5 0.004).mean posi et al., 1971; Garg et al., 1972; Karpatkin, 1978; Levin
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10 RUSSELL ET AL.nd Bessman, 1983). Patients with thrombocytopenia
econdary to bone marrow failure often have decreases
n MPV (Levin and Bessman, 1983; Bessman et al., 1985;
aynes et al., 1988). Thrombocytopenic EIAV-infected po-
ies had increased MPV late in infection compared to
reinfection, which is consistent with enhanced bone
arrow production and accelerated release of young
latelets.
The presence of reticulated platelets in circulation
s used to estimate the rate of bone marrow platelet
roduction (Burstein and Breton-Gorius, 1995) and
ids in differentiating between increased platelet de-
truction and decreased bone marrow production (Kie-
ast and Schmitz, 1990; Miyachi and Ando, 1992; Ault,
993; Rinder et al., 1993; Romp et al., 1994; Richards
nd Baglin, 1995). Increased circulating reticulated
latelets occur when thrombocytopenia is secondary
FIG. 2. The percentage of reticulated platelets in circulation over time
onitored in two ponies following the initial thrombocytopenic/febrile e
rom the Wyoming wild-type strain of EIAV (see Materials and Methodo increased platelet destruction (Kienast and Schmitz, (990; Ault, 1993). There is a direct correlation between
PV and the percentage of circulating reticulated
latelets (Kienast and Schmitz, 1990). Concomitant
ith thrombocytopenia and increased MPV, the ponies
n this study had increased percentages of circulating
eticulated platelets. As peripheral platelet counts re-
ounded, the percentage of circulating reticulated
latelets decreased. These findings suggest that bone
arrow platelet production was not severely compro-
ised and the bone marrow was able to mount a
egenerative response.
Bone marrow morphometry has been used to evaluate
egakaryocyte response to thrombocytopenia (Odell et
l., 1976; Thiele et al., 1991, 1992; Kaloutsi et al., 1994;
ardrop et al., 1996). Indications of compensatory
egakaryocytopoiesis include increases in megakaryo-
yte numbers, cytoplasmic mass, and DNA synthesis
t counts and the percentage of reticulated platelets in circulation were
Both of these ponies were inoculated with an infectious clone derived
—) Platelet count; (–p–) percentage of reticulated platelets.. Platele
pisode.Ebbe et al., 1968; Harker, 1968; Odell et al., 1976; Corash
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11THROMBOCYTOPENIA AND EIAVt al., 1987). In our study, total megakaryocyte area and
egakaryocyte nuclear area were significantly in-
reased in bone marrow from acutely infected ponies
ompared to controls. This is compatible with the pres-
nce of a regenerative bone marrow megakaryocyte
esponse to thrombocytopenia. Numbers of megakaryo-
ytes were also slightly increased; however, the finding
as not statistically significant. In humans with immune-
ediated thrombocytopenia, numbers of megakaryo-
ytes can range from normal to increased (Ballem et al.,
987; Siegel et al., 1989; Tomer et al., 1991).
Our results indicate that thrombocytopenia associated
ith acute EIAV infection is regenerative, an anticipated
nd typical response with peripheral platelet destruction.
mmune-mediated platelet destruction and impaired
latelet production by bone marrow megakaryocytes
ave been implicated in the pathogenesis of EIAV-asso-
T
Morphologic Analysis of Bone Marrow from 8 Unin
Parameter
Uni
Median
Platelet count (platelets/ml) 172,000
Megakaryocyte/mm2 18.5
Bare nuclei/mm2 0.5
Megakaryocyte area (mm2) 459
Megakaryocyte nuclear area (mm2) 146
Nuclear area:Total area ratio 0.315
a A Mann–Whitney rank sum test was used to analyze data. Median
FIG. 3. Platelet activation in uninfected ponies (n 5 8) and ponies
ssessed by measuring the amount of fibrinogen bound to platelet memluorescence. A Mann–Whitney rank sum test was used to analyze the data.iated thrombocytopenia. Clabough et al. found that in-
reased platelet-associated IgG and IgM occurs concur-
ently with decreasing platelet counts and increasing
everse transcriptase activity in ponies acutely infected
ith EIAV; a finding compatible with immune-mediated
estruction (Clabough et al., 1991). Platelet life span is
ecreased in EIAV-infected animals (Crawford et al.,
996). SCID foals infected with EIAV become thrombocy-
openic, demonstrating that immune-specific responses
re not needed to cause EIAV-associated thrombocyto-
enia (Wardrop et al., 1996; Tornquist et al., 1997). If bone
arrow is capable of continued platelet production in
cutely infected EIAV ponies and immune responses are
ot necessary for thrombocytopenia to develop, nonim-
une-mediated platelet destruction should be consid-
red an alternative or additional mechanism for EIAV-
ssociated thrombocytopenia.
Horses and 4 Ponies Acutely Infected with EIAV
a Infecteda
25th, 75th
Percentiles Median
25th, 75th
Percentiles
8,000, 240,000 11,000*** 10,000, 34,000
17.5, 26.0 22.5 19.5, 24.55
0, 1 0.0 0, 1
434.5, 571.5 721.5*** 696.5, 1006
130, 198.5 246.5*** 216, 369.5
0.30, 0.365 0.345 0.32, 0.365
are shown with the 25th and 75th percentiles (***P , 0.05).
y infected with EIAV (n 5 5) at late infection. Platelet activation was
. The measurement of surface-bound fibrinogen is expressed as meanABLE 1
fected
nfected
14acutel
branesThe median 6 25th and 75th percentiles is given (***P , 0.05).
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12 RUSSELL ET AL.In vivo platelet activation can result in formation of
latelet aggregates or platelet lysis with accelerated
emoval of damaged platelets from circulation. In vivo
latelet activation can also result in a state of “platelet
xhaustion” whereby platelets become refractory to the
ffects of additional stimulation (Pareti et al., 1980; Coss-
riff, 1989). Antibody or immune complexes bound to
latelet surfaces, cytokines, and damaged endothelium
an cause in vivo platelet activation (Clancy et al., 1972;
arpatkin and Lackner, 1975; Heyns et al., 1978; Curwen
t al., 1980; Stuart et al., 1981; Cossgriff, 1989; Oleksowicz
t al., 1991, 1994; Yanabu et al., 1991; Christie and Swine-
art, 1992; Burstein, 1994; Peng et al., 1994). Platelets
rom ponies acutely infected with EIAV had increased
urface bound fibrinogen and ultrastructural changes
onsistent with in vivo activation. These platelets had
ecreased aggregation responses to ADP, collagen, and
AF in vitro. In vitro experiments to identify whether
mmune complexes or free virus could cause platelet
ctivation were unsuccessful. Because these findings
uggest that virus or immune complexes do not appear
o cause platelet activation, we propose that damaged
ndothelium may be an additional factor that contributes
FIG. 4. Transmission electron micrographs of platelets from a represe
ith EIAV at late infection. Platelets from the infected ponies displ
seudopodia formation, and granule centralization (C through F). Very
morphous debris, possibly representing degranulated platelets, was p
, F, and H, 310,400.o in vivo platelet activation. eDirect damage of endothelial cells has been demon-
trated with filoviruses (Geisbert et al., 1992; Schnittler et
l., 1993), orbiviruses (Laegreid et al., 1992), and herpes
implex virus (Key et al., 1990). Indirectly, infection and
ctivation of macrophages with subsequent release of
ytokines, such as TNFa, can result in increased endo-
helial cell permeability (Feldmann et al., 1996). Platelet
dhesion and aggregation can be stimulated by the
elease of PAF and von Willebrand factor from the endo-
helium. Endothelial activation with the release of these
ubstances can be induced by infectious products, he-
odynamic factors, plasma constituents, and cytokines.
urthermore, these can cause endothelial damage and
xposure of subendothelial tissue (primarily collagen),
elease of tissue factor, and other products. In any of
hese situations, platelets would be activated. EIAV is
apable of infecting endothelial cells (Crawford et al.,
996; Maury et al., 1998). We have preliminary data from
ne pony with increased concentrations of tissue plas-
inogen activator inhibitor in plasma. Future experi-
ents will concentrate on whether endothelial damage
ccurs in our model.
It is difficult to quantitate maximum platelet regen-
normal pony (A and B) and three ponies (C through G) acutely infected
ormal ultrastructural changes that include a more rounded shape,
telets from the third infected pony were intact and a large amount of
(G and H). Original magnifications: A, C, and G, 33000; E, 32400; B,ntative
ay abn
few pla
resentrative ability in vivo. The regenerative response ob-
s
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13THROMBOCYTOPENIA AND EIAVerved in the ponies of this study may not be maximal.
ifferences between results in this study and a previ-
us report are likely due to inherent differences in
ensitivity of the methodology used and in the specific
odel studied. Ponies infected with the Wyoming wild-
ype strain of EIAV become more rapidly and severely
hrombocytopenic than those infected with some other
trains of EIAV. Early in the infection bone marrow may
e more capable of responding to thrombocytopenia
han later in infection. Platelet kinetics and response
o thrombocytopenia may differ between adult ponies
sed in this study and foals. In previous studies, plate-
et production was measured using a metabolic radio-
sotope incorporation assay (Crawford et al., 1996).
his technique is based on incorporation of [75Se]sel-
nomethioine or [35S]sulfur into megakaryocyte mac-
omolecules but not directly into platelets (Evatt and
evin, 1969). Megakaryocytes and platelets bind and
nternalize proteins (Handagama et al., 1990); there-
ore, the accuracy of the assay may be questionable
nder certain conditions (Burstein and Breton-Goruis,
995). Furthermore, because measurements for this
ssay are obtained from circulating platelets, a de-
rease in platelet survival, as occurs in EIAV-infected
orses, could result in underestimation of platelet pro-
uction by this method (Schulman and Jordan, 1987).
FIG. 4EIAV-associated thrombocytopenia shares many sim- alarities with HIV-related thrombocytopenia. With both
iruses, peripheral platelet destruction and decreased
latelet production are important in the pathogenesis of
iral-associated thrombocytopenia. Ponies infected with
IAV are an ideal model for studying the pathogenesis of
iral-associated thrombocytopenia. Thrombocytopenia
ssociated with acute EIAV infection is consistent, repro-
ucible, and closely linked with viremic episodes. In our
odel, increases in MPV, reticulated platelets, and in-
reases in bone marrow megakaryocyte cell and nuclear
rea imply that bone marrow megakaryocytes remain
apable of continued platelet production. Additional in-
irect evidence that platelet destruction may be impor-
ant in the pathogenesis of EIAV-related thrombocytope-
ia is the finding that platelets from these ponies were
ctivated in vivo and hypofunctional. Our results suggest
nother mechanism whereby peripheral platelet destruc-
ion could occur in either immune-deficient or immune-
ompetent horses infected with EIAV.
MATERIALS AND METHODS
irus and experimental infections
Adult ponies were infected with Wyoming wild-type
train 158 of EIAV (n 5 5) or virus derived from a virulent
nfectious molecular clone of EIAV (n 5 4) (Clabough et
inuedl., 1991; Payne et al., 1998). Two of the ponies infected
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14 RUSSELL ET AL.ith Wyoming wild-type were used for platelet aggrega-
ion or morphometric analysis only. Wyoming wild-type is
virulent strain of EIAV that consistently causes acute
isease (high fever and thrombocytopenia) in horses
Malmquist et al., 1973; Clabough et al., 1991). The titer of
his stock was determined to be approximately 106 infec-
ious doses per milliliter (ml) using horse inoculation
ssay. The clinical course of the acute febrile and throm-
ocytopenic episode in ponies infected with molecular
lones in EIAV was virtually identical to that seen in
onies infected with the Wyoming wild-type strain of
IAV (Table 2). Because there was no difference in the
linical presentation during the acute febrile/thrombocy-
openic episode of ponies inoculated with the infectious
olecular clones of EIAV or the Wyoming wild-type strain
f EIAV, data from both were combined. Two of the four
onies inoculated with virus derived-infectious molecu-
ar clones of EIAV recovered from the initial acute febrile/
hrombocytopenic episode and experienced cyclic epi-
odes of high fever and thrombocytopenia.
Infected ponies were housed in isolation stalls. Body
emperature, appetite, and attitude/mentation were mon-
tored daily. Complete blood counts, including platelet
ounts and mean platelet volume (SeronoBaker 90101
ematology Analyzer, SeronoBaker, Allentown, PA), were
erformed every other day for the first week following
nfection and then daily until the end of the study. Viremia
as monitored using serum reverse transcriptase activ-
ty (Clabough et al., 1991). Ponies infected with Wyoming
ild-type were humanely euthanized when body temper-
FIG. 5. Platelet aggregation in ponies (n 5 6) acutely infected with
ggregation/platelet to three agonists (ADP 1.0 mM, collagen 1.0 mM, a
ata. Mean 6 standard deviation is given (*P 5 0.003, **P 5 0.0003,ture exceeded 40°C. Ponies infected with clones of tIAV displayed cyclic bouts of fever and thrombocytope-
ia. The duration of experimental infections was approx-
mately 2 weeks. Experiments in this study were ap-
roved by the Institutional Animal Care and Use Com-
ittee of North Carolina State University.
ean platelet volume
Mean platelet volume (MPV) was obtained from the
omplete blood count. Six ponies were analyzed before
nfection and when the ponies became thrombocytope-
ic (platelet count ,75,000/ml). The MPV value of one of
he ponies was excluded from the analysis due to plate-
et clumping observed on peripheral blood films.
eticulated platelet analysis
Blood from seven EIAV-infected ponies was analyzed
reinfection and during the acute infection period to
etermine the percentage of circulating reticulated plate-
ets. Uninfected, normal ponies were used as controls.
nalysis for reticulated platelets was performed as pre-
iously described (Russell et al., 1997). Briefly, blood was
ollected into an EDTA tube by jugular venipuncture
sing a Vacutainer system (Becton–Dickinson, Ruther-
ord, NJ). Five microliters of whole anticoagulated blood
as added to 1 ml of Thiazole Orange ReticCount (Bec-
on–Dickinson Immunocytometry Systems, San Jose,
A). The sample was briefly vortexed and incubated in
he dark at 25°C. After 90 min, samples were analyzed by
low cytometry using a FacSCAN flow cytometer (Bec-
at preinfection and early, mid, and late infection. The rate of platelet
0.1 mM) was measured after 5 min. Paired t test was used to analyze
0.02).EIAV
nd PAFon–Dickinson Immunocytometry). The instrument was
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15THROMBOCYTOPENIA AND EIAValibrated daily prior to analysis, using fluorescent beads
CaliBRITE flow cytometry beads, Becton–Dickinson Im-
unocytometry) and calibration software (AutoCOMP,
alibration software, Becton–Dickinson Immunocytom-
try Systems). Forward scatter (FSC), right angle side
catter (SSC), and fluorescence (FL-1) were measured. A
ot plot of FSC versus SSC was generated, a gate was
rawn around the platelet cloud, and 10,000 events were
ollected. For analysis, FL-1 logarithmic histograms were
enerated. Defined regions on the FL-1 histograms from
he normal control animals were calculated, averaged,
nd applied to the histograms from infected ponies to
etermine the percentage of reticulated platelets. Anal-
sis of reticulated platelets was performed using the
nstrument software Lysis II (Becton–Dickinson Immuno-
ytometry Systems).
one marrow morphometric analysis
Bone marrow from four acutely infected ponies was
btained from a rib fixed in 10% buffered Formalin, de-
alcified and embedded in paraffin, and stained with
ematoxylin/eosin for histopathological evaluation. Bone
arrow from uninfected horses (n 5 8) was obtained
hrough the necropsy service at North Carolina State
niversity College of Veterinary Medicine. These sam-
les were selected on the basis that no hematological
T
Characterization of Clinical Presentation during Acute Febrile/Throm
Strain of EIAV and Infectious Molec
ony Virus strain
Preinfection platelet
count/ml
1 Wyoming wild-type 78,000c
2 Wyoming wild-type 137,000
3 Wyoming wild-type 133,000
4d Wyoming wild-type 226,000
5d Wyoming wild-type 233,000
Mean 182,300
Standard deviation 54,700
n 4c
6 p19/wenv17 303,000
7 p19/wenv17 202,000
8 p19/wenv17 188,000
9 p19/wenv16 216,000
Mean 227,000
Standard deviation 51,800
n 4
Note. The mean and standard deviation is given for each group of p
a PID, postinfection day when lowest platelet count or peak tempera
b Outcome of pony following first febrile/thrombocytopenic episode.
c Platelets from this pony clumped in EDTA; the actual count could no
alculation of the mean and standard deviation given for preinfection
d Ponies 4 and 5 were used only in morphometric analysis or platel
e Actual platelet counts reported from these ponies were lower; how
s 20,000/ml; therefore, any number below this value should not be cobnormalities were present in these animals at the time af death. Slides were labeled and morphometric analysis
sing Image-Pro Plus Systems (Silver Spring, MD) was
erformed. Parameters analyzed included number of
egakaryocytes/mm2 area, number of bare megakaryo-
yte nuclei/mm2 area (megakaryocyte nuclei denuded of
ytoplasm), megakaryocyte area in mm2, megakaryocyte
uclear area in mm2, and the megakaryocyte nuclear
rea to total megakaryocyte area ratio.
latelet activation
Platelet activation was analyzed in 8 normal ponies
nd 5 EIAV-infected ponies at peak infection. Analysis of
latelet activation was performed as previously de-
cribed (Welles et al., 1994) with the following modifica-
ions. Whole blood was collected by a traumatic jugular
enipuncture, allowing it to drip directly into a 4.5-ml
lood collection tube containing 3.8% sodium citrate and
mg/ml prostaglandin E1 (Sigma Chemical, St. Louis,
O) to prevent in vitro platelet activation. Blood was
entrifuged at 150 g for 15 min to obtain platelet-rich
lasma (PRP). Aliquots (10 ml) of platelet-rich plasma
ere fixed overnight in 1 ml fresh 2% paraformaldehyde.
he sample was not included in the study if a difficult
enipuncture occurred which could result in iatrogenic
latelet activation.
Fixed platelets were centrifuged at 270 g for 10 min
openic Episodes of Ponies Inoculated with the Wyoming Wild-Type
ones Derived from Wild-Type EIAV
owest platelet
ount/ml (PID)a
Peak temperature (°C)
(PID)a Outcomeb
58,000 (10) 40.1 (10) Euthanized
20,000e (15) 39.4 (15) Euthanized
20,000e (12) 41.4 (10) Euthanized
45,000 (14) 40.5 (10) Euthanized
59,000 (14) 40.3 (12) Euthanized
40,400 40.3
19,400 0.6
5 5
20,000e (14) 40.1 (11) Recovered
27,000 (13) 40.7 (16) Euthanized
24,000 (14) 40.9 (17) Euthanized
53,000 (13) 38.9 (11) Recovered
31,000 40.0
14,900 1.1
4 4
curred.
termined but is likely to be higher. This value was not included in the
count.
egation studies, respectively.
e lower limit of linearity of the hematology analyzer for platelet counts
d valid.ABLE 2
bocyt
ular Cl
L
c
onies.
ture oc
t be de
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ever, thnd the supernatant was discarded. The pellet was re-
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16 RUSSELL ET AL.uspended in 0.5 ml 0.2% BSA in 0.15 M NaCl and
tained with a fluorescein-conjugated goat F(AB9)2 frag-
ent to human fibrinogen antibody (Cappel, Organon
ecknika Corp., West Chester, PA) at a 1:500 dilution.
amples were incubated for 30 min at 25°C. Following
ncubation samples were analyzed for platelet activation
sing flow cytometry in a manner similar to that de-
cribed for reticulated platelet analysis. Mean fluores-
ence of the platelet population was used to assess the
resence or the absence of platelet activation. Prelimi-
ary platelet activation studies using normal equine
latelets incubated without an agonist or with ADP, col-
agen, or PAF showed that fibrinogen could be used to
istinguish between activated and resting platelets (Figs.
a–6d).
ransmission electron microscopy
Blood was collected in a manner similar to that for
latelet activation. An aliquot (100 ml) of platelet-rich
lasma was added to 1 ml Trumps fixative and pro-
FIG. 6. Detection of nonactivated and activated platelets using surf
ncubated for 3 min (A) in the absence of an agonist or with (B) 1.0 mM A
ixed in paraformaldehyde, stained with a fluorescein-conjugated goat F
ean fluorescence of the population (%) was used to assess plateletessed for transmission electron microscopy. After fixa- fion, platelets were pelleted at 1200 rpm for 10 min and
laced in 1% osmium tetroxide in buffer for 1 h at room
emperature. Samples were rinsed two times in distilled
ater and dehydrated in an ethanolic series with two
inal changes in 100% acetone. Cells were placed in a
ixture of Spurr resin and acetone at a 1:2 dilution for 30
in, followed by a 2-h incubation in 100% resin with two
hanges. Samples were placed in fresh 100% resin in
olds and polymerized at 70°C for 8 h. Semithin (0.25–
.5 mm) sections were stained with 1% toluidine blue-O
n 1% sodium borate. Ultrathin (70–90 nm) sections were
tained with methanolic uranyl acetate followed by lead
itrate and examined with a transmission electron mi-
roscope.
latelet aggregation
Blood from six EIAV-infected ponies was used to as-
ess platelet aggregation. As an internal control for each
ggregation study, blood from an uninfected, normal
ony was analyzed the same day as that from the in-
nd fibrinogen on platelet membranes. Normal equine platelets were
1.0 mM collagen, or (D) 0.1 mM platelet-activating factor. Platelets were
ragment to human fibrinogen antibody, and analyzed by flow cytometry.
on. (A, 33.03; B, 61.02; C, 59.09; D, 54.67).ace-bou
DP, (C)
(AB9)2 fected pony. In four ponies, platelet aggregation was
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17THROMBOCYTOPENIA AND EIAVerformed at least one time before infection and moni-
ored three times during the acute infection period: early
n the infection period, midway through the infection
eriod, and late in the infection period. These times were
esignated as pre, early, mid, and late infection and
orrespond to approximate postinfection days (PID) 0,
–4, 7–9, and 13–15, respectively. Platelet aggregation for
he remaining two EIAV-infected ponies was performed
reinfection and late infection.
Nine parts whole blood to 1 part 3.8% sodium citrate
nticoagulant was collected by atraumatic venipuncture
nto a 60-ml syringe. Blood was transferred to 50-ml
olypropylene tubes and centrifuged at 150 g for 15 min
o obtain platelet-rich plasma (PRP). Platelet-poor
lasma (PPP) was prepared by centrifuging an aliquot of
he citrated blood at 1200 g for 12 min. Manual platelet
ounts on the PRP were performed (Unopette Microcol-
ection System, Becton–Dickinson, Rutherford, NJ). Plate-
et concentration was adjusted with PPP so that the final
oncentration of platelets used in the aggregation stud-
es was equivalent for the normal control pony and the
nfected pony. Platelet aggregation was performed using
whole blood dual channel lumiaggregometer equipped
ith a recorder (Chrono-Log Corp., Havertown, PA).
latelet-rich plasma was incubated in siliconized cu-
ettes for 15 min to allow the sample to reach 37°C
efore agonists were added. All aggregation studies
ere completed within 3 h from time of blood collection.
Three agonists were used to assess platelet aggrega-
ion in this study: collagen, adenosine diphosphate
ADP), and platelet-activating factor (PAF). For aggrega-
ion studies, 5 ml stock solution of the appropriate ago-
ist was added to PRP. Collagen and ADP (Chrono-Log
orp.) were used at a final concentration of 1.0 mM. PAF
Sigma Chemical) was used at a final concentration
f 0.1 mM.
To evaluate platelet aggregation responses, the rate of
ggregation (slope of the aggregation curve at the steep-
st point) was measured. This measurement was stan-
ardized by dividing slope by the number of platelets in
RP (O’Brien, 1971; Newhouse and Clark, 1978). The
esults are reported as the rate of aggregation/platelet.
tatistical analysis
The data were analyzed using the statistical software
rogram SigmaStat (Jandel Scientific, San Rafael, CA).
ata with a normal distribution were analyzed using a
aired t test. Data with a nonparametric distribution were
nalyzed using a Mann–Whitney rank sum test. A P value
f ,0.05 was considered significant.
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